Smoking cessation and incident cardiovascular disease
Cho JH, Shin SY, Kim H, et al.
JAMA Netw Open. 2024;7(11):e2442639.
Leggi
Pathophysiology of vascular ageing and the effect of novel cardio-renal protective medications in preventing progression of chronic kidney disease in people living with diabetes
Fountoulakis N, Miyamoto Y, Pavkov ME, et al.
Diabet Med. 2024:e15464.
Leggi
FDA: Preventing Damage to Wearable Diabetes Devices During Imaging and Radiation Procedures
15/10/2024
Leggi
Once-weekly semaglutide in persons with obesity and knee osteoarthritis
Bliddal H, Bays H, Czernichow S, et al.
N Engl J Med. 2024 Oct 31;391(17):1573-1583
Leggi
European Society for the Study of Obesity (EASO) Position Statement on medical nutrition therapy for the management of individuals with overweight or obesity and cancer
Muscogiuri G, Barrea L, Bettini S, et al.
Obes Facts. 2024:1-37.
Leggi
GLP-1 receptor agonist and SGLT2 inhibitor prescribing in people with type 1 diabetes
Li P, Li Z, Staton E, et al.
JAMA. 2024:e2418581.
Leggi
Intermittently scanned continuous glucose monitoring compared with blood glucose monitoring is associated with lower HbA1c and a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies
Nathanson D, Eeg-Olofsson K, Spelman T, et al.
Diabetologia. Pub. online 26 Oct 2024.
Leggi
Risk of infection in older adults with type 2 diabetes with relaxed glycemic control
Lipska KJ, Gilliam LK, Lee C, et al.
Diabetes Care. 2024:dc241612.
Leggi
National health and economic impact of a lifestyle program to prevent type 2 diabetes mellitus in Germany: a simulation study
Ogurtsova K, Laxy M, Emmert-Fees K, et al.
BMJ Open Diabetes Res Care. 2024;12(5):e004382.
Leggi
Synergies between diabetes and hyperhomocysteinaemia: New insights to predict and prevent adverse cardiovascular effects
Fan X, Liu Y, Chen X, et al.
Diabetes Obes Metab. Pub. online 21 Oct 2024.
Leggi